Abstract
Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have